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Atopic dermatitis (AD) is a chronic inﬂammatory skin disease which has a complex etiology that encompasses immunologic
responses. The study was carried out to examine the eﬀect of Nelumbo nucifera (Gaertn.) leaf (NL) on the AD-like skin lesion
induced by repeated epicutaneous application of 2,4-dinitrochlorobenzene (DNCB) on the dorsal skin of NC/Nga mice. Three
diﬀerent doses of NL (5, 25, and 50mg/mice/day) were administered orally from the day of sensitization with DNCB for 4 weeks.
The eﬃcacy of NL was judged by histopathological examination, blood IgE level, measurement of transepidermal water loss
(TEWL), scratching behavior, and skin severity score. NL resulted in the suppression of clinical severity score, TEWL, scratching
behavior, and blood IgE level. Histopathologic analyses revealed that thickening of the epidermis and mast cell degranulation was
signiﬁcantly reduced in NL group. These results suggest that NL may be a useful natural resource for the management of AD.
1.Introduction
Atopic dermatitis (AD) is a chronic and relapsing inﬂamma-
tory skin disease relying on the interplay of environmental,
immunological, and genetic factors [1]. The prevalence of
AD has increased dramatically in the past 3 decades and the
increase in recent years can be attributed to environmental
inﬂuences including industrialized and urban settings [2].
Epidemiological reports suggest that AD aﬀects up to 10–
20%ofchildrenworldwideandcanpersistintoadulthood. It
has been estimated that AD symptoms are developed among
65% of patients in the ﬁrst year of life and among 90% of
the patients before the age of ﬁve [3]. The lesional skin in
ADischaracterizedbyedema,hemorrhage,erosion,dryness,
and alopecia typically localized on the ears, back, and neck
and in the facial region [4]. Pathological examination of
the lesional skin in AD reveals spongiosis, hyperkeratosis,
and parakeratosis in acute lesions and marked epidermal
hyperplasia, acanthosis, and perivascular accumulation of
lymphocytes and mast cells in chronic lesions [5]. Although
the complex interrelationships between genetic, environ-
mental, skin barrier, pharmacological, psychological, and
immunological factors contribute to the pathogenesis of AD,
the immunological basis of the disease is of considerable
importanceandhasbeenextensivelystudied[6].Theallergic
diseases like AD, asthma, and rhinitis are characterized
by Th2-dominated responses, which are mediated by IL4,
IL-5, and IL-13 and induce B-cell class switching to IgE
[7]. NC/Nga mice were established as an inbred strain
from Japanese fancy mice in 1957 and have recently been
shown to spontaneously develop AD-like dermatitis with IgE
hyperproduction in air-uncontrolled, conventional circum-
stance [8, 9]. NC/Nga mice, however, show no skin lesion
when raised in speciﬁc-pathogen-free (SPF) condition. An
epicutaneous application with chemical antigens such as
picryl chloride evokes contact hypersensitivity reaction in
mice that had previously been sensitized with same agents.
Interestingly, repetition of the topical application with such
agents not only induces a shift in kinetics of the skin
reaction from delayed-type to immediate-type response but2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Clinical skin symptoms. Three diﬀerent doses of NL (5, 25, and 50mg/mice/day) were administered orally from the day of DNCB
sensitization. The photographs were taken on day 28 before the sacriﬁce of the mice.
also changes the cytokine milieu from Th1 to Th2 proﬁle
[10, 11].
Nelumbo nucifera Gaertn. (Nymphaeaceae), a large
aquatic herb widely found in India, China, Japan, and Korea,
not only possesses ornamental and dietary value but also
has been using as a medicinal herb in eastern Asia. Almost
every part of N. nucifera including leaves, ﬂowers, seeds, and
rhizomes has been reported to possess diﬀerent therapeutic
eﬀects [12] .T h el e a v e sh a v eb e e nm e n t i o n e dt os h o w
antiobesity activity by increasing lipolysis in the adipose
tissue of mice [12, 13]. There are reports on N. nucifera
rhizome possessing acetylcholinesterase activity and semen
possessing antidiarrheal and tranquilizing activities [14]. N.
nucifera is rich in alkaloids and ﬂavonoids. Moreover, N.
nucifera leaves contain abundant amount of ﬂavonoids like
luteolin, quercetrin, and isoquercitrin [15]. In this paper, the
eﬀects of water extract of N. nucifera leaves (NLs) on the
slink skin symptoms of NC/Nga mice caused by the repeated
topical application of DNCB (2, 4-dinitrochlorobenzene)
were evaluated.
2.MaterialsandMethods
2.1. Animals. Male 5-week-old NC/Nga mice (20–23 grams
body weight) were purchased from SLC Inc. (Tokyo, Japan).
Themicewerekeptinstandardplasticcagesundercontrolled
temperature (25 ± 5◦C), humidity (50 ± 10%), 100% fresh
hepa-ﬁltered air, and 24 hours light-dark cycle (lights on
from 06:00 to 18:00) in the Animal Research Center of
Mokpo National University. The mice were supplied with
basal diet and sterilized water without any restriction during
the experiment. All mice were acclimated for a week prior
to the initiation of experiments. All animal studies were
approved by the Animal Care Committee of the Graduate
School of Natural Sciences, Mokpo National University, and
all husbandry practices and animal care were in accordance
with the guidelines of Korean Council on Animal Care.
2.2. Reagents. DNCB was purchased from Sigma-Aldrich,
Inc. (St. Louis, MO, USA). Olive oil and acetone were
purchasedfromKantoChemicalCo.,Inc.(Tokyo,Japan)and
Carlo erba Reagents SA. (France), respectively. DNCB was
dissolved in olive oil/acetone (3:1) as 1% (w/v) and 0.4%
(w/v) solution and used for the sensitization and elicitation.
2.3. Application of DNCB. Dorsal hair of NC/Nga mice was
removed by using electric shaver and hair removing cream
containing 80% of thioglycolate. On the next day, the dorsal
skin was sensitized with 200µL of 1% DNCB (w/v) in olive
oil/acetone (3:1). Four days later, the mice were challenged
by applying 200µL of 0.4% DNCB (w/v) on the dorsal skinEvidence-Based Complementary and Alternative Medicine 3
repeatedly 3 times per week (Monday, Thursday, and Sat-
urday) for 4 weeks. Each group contained 7 mice.
2.4. Preparation of Nelumbo nucifera Leaf (NL) Extract.
Leaves of N. nucifera were obtained from Muan, Korea. The
leaves (1Kg) were extracted with 3000mL of distilled water
by using soxhlet extractor for 3 hours, and the extraction was
r e p e a t e df o r3t i m e s .T h er e s i d u ew a sr e m o v e db yﬁ l t r a t i o n
and then the ﬁltrate was evaporated and freeze-dried to give
the powder of NL. The yield of the dried extract was about
12% of the starting material.
2.5.AdministrationofNL. NLwasdissolvedindistilledwater
and fed to the mice per orally using gastric sonde from the
day of sensitization until 4 weeks. The control was fed with
distilled water. NL was administered at 3 diﬀerent doses (5,
25, and 50mg/mice/day).
2.6. Transepidermal Water Loss (TEWL). TEWL on the
dorsal skin of mice was measured using a skin evaporative
water recorder (Tewameter TM300; Courage and Khazawa,
Cologne, Germany). The resulting data were analyzed by
the microprocessor and were expressed in g/m2/h. TEWL
was measured in each week for 4 weeks. Measurements were
recorded when TEWL readings were stabilized at approxi-
mately 30 seconds after the probe was placed on the skin.
2.7. Evaluation of Scratching Behavior and Blood IgE Level.
Mice were placed individually in a clear plastic cage and
allowed to acclimatize for 15 minutes. Thereafter, behavior
was videotaped for 10 minutes. Scratching of the nose,
ears, and dorsal skin with the hind paws was observed
during playback. Licking of the belly and dorsal skin during
grooming was disregarded. Each occurrence of scratching
of the head, neck, dorsal skin, ears, and nose was scored
to obtain the maximum score. The IgE level in blood was
measured using IgE kit (Shibayagi Co. Ltd., Gunma, Japan)
according to the manufacturer’s instructions.
2.8. Evaluation of Skin Severity. The severity of dermatitis
on the face, ears, and dorsal part of the body was assessed
blindly. The evaluated symptoms consisting of (i) ery-
thema/hemorrhage, (ii) pruritus and dry skin, (iii) edema,
(iv) excoriation/erosion, and (v) licheniﬁcation were scored
as follows: none = 0; mild = 1; moderate = 2; severe = 3. The
sum of the scores for each evaluated symptom (maximum
score: 15) was considered as the skin severity score. The skin
severity was evaluated every week for 4 weeks.
2.9. Histopathological Examination. After 4 weeks, all the
mice were euthanatized under diethyl ether anesthesia and
the dorsal skin was excised, ﬁxed in 10% phosphate-buﬀered
formalin (pH 7.2), and embedded in paraﬃn. Sections of
4µm were microtomed. The sections were deparaﬃnized
in xylene, dehydrated in graded alcohol bath, and stained
with hematoxylin and eosin or acidiﬁed toluidine blue.
Finally, they were examined through optical microscope
(Olympus, Tokyo, Japan), and thickness of epidermal layer
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Figure 2: Skin severity score. The skin severity of mice was assessed
macroscopically in a blinded fashion as mentioned in Section 2.
The symptoms considered were (i) erythema/hemorrhage, (ii)
pruritus and dry skin, (iii) edema, (iv) excoriation/erosion, and (v)
licheniﬁcation. aP<0.05versus control.
was calculated using Aperio ImageScope image analysis. The
number of mast cells per square millimeter of dermis in
four sites chosen at random was counted from the toluidine
stained sections.
2.10. Statistical Analysis. All the experimental data were ex-
pressed as mean ± standard deviation. The signiﬁcance of
variation among diﬀerent groups was determined by one-
way ANOVA analysis. P value ≤ 0.05 was considered to be
signiﬁcantly diﬀerent.
3. Results
3.1. Eﬀe c to fN Lo nS k i nS e v e r i t y .NC/Nga mice have been
shown to develop AD-like skin lesions by repeated applica-
tion of picrylchloride. The skin severity in control was in-
creased gradually with the number of DNCB challenges.
Oral administration of NL for 4 weeks suppressed the
development of AD-like skin lesions. The skin severity of
each group on day 28 is as shown in Figure 1. Skin severity
in each group was more or less similar up to 14 days
from the day of sensitization. But after 14 days, there was
drastic change in the skin symptoms of control than NL-
administered groups. The skin severity score of each group
is as shown in Figure 2.
3.2. Histopathological Analyses. Hematoxylin and eosin
staining of the dorsal skin sections revealed hyperkeratosis,
parakeratosis, acanthosis with varying degrees of spongiosis,
exocytosis of mononuclear cells in the epidermis, and
inﬁltration of inﬂammatory cells into the upper dermis of
control group while all those parameters were suppressed
in NL-administered groups as shown in Figure 3(a).T h e
quantitative data of epidermal thickness are as shown in4 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Histopathological changes. The dorsal skin excised at the end of the experiment was ﬁxed in formalin, microtomed in 4µm
sections, and stained with hematoxylin and eosin (magniﬁcation 400x). The thickness of epidermal layer was calculated using Aperio
ImageScope V9.1.19.1571 image analysis. aP < 0.05 versus control.
Figure 3(b). The epidermal thickness of control was 88.668±
15.2µm while that of NL50 was 61.288 ± 21µm( P<0.05).
Toluidine blue staining of the dorsal skin sections revealed of
moreinﬁltrationanddegranulationofmastcellsintheupper
dermis of control than NL-administered groups as shown in
Figure 4(a). The quantitative data on mast cell inﬁltration
and degranulation are as shown in Figure 4(b).T h en u m b e r
of mast cells per millimeter square in control, NL5, NL25,
andNL50 wasfoundto be67±20, 41±18, 44±13, and 41±
9, respectively.
3.3. Eﬀe c to fN Lo nB l o o dI g EL e v e l . The epicutaneous sensi-
tization and challenge of dorsal skin of NC/Nga mice with
DNCB elevated the Ig E level from 1.36 ± 0.435µg/mL
(normal, nontreated group) to 6.87 ± 0.286µg/mL. The
administration of NL50 suppressed the IgE level to 3.5 ±
0.93µg/mL, which was the suppression approximately by
2 folds against the control. Similarly, NL25 suppressed the
elevation of IgE to 4.7 ± 0.8µg/mL which was statistically
signiﬁcant (P<0.05). Figure 5 shows the eﬀect of NL on
the blood IgE level on day 28.Evidence-Based Complementary and Alternative Medicine 5
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Figure 4: Mast cell degranulation. The dorsal skin excised at the end of the experiment was ﬁxed in formalin, microtomed in 4µm
sections, and stained with acidiﬁed toluidine blue. The number of mast cells/unit area of dermis in 4 sites chosen at random was counted.
(magniﬁcation, 400x), arrow heads showing degranulated mast cells.
3.4. Eﬀect of NL on Scratching Behavior and TEWL. There
was no diﬀerence in the average number of scratching
behavior among the groups up to 14 days. However, there
were changes in the scratching behavior among the groups
from the 3rd week. The scratching behavior evaluated on
day 25 is as shown in Figure 6. The number of scratching
was decreased by more than threefold in NL50. Consistent
with eﬀect of NL on mast cell degranulation, NL decreased
the scratching behavior. TEWL of NL-administered groups
was not diﬀerent from control up to 14 days. However,
administration of NL25 and NL50 signiﬁcantly inhibited
TEWL on days 21 and 28 (Figure 7).
4. Discussion
AD is a chronic inﬂammatory skin disease which has a com-
plex etiology, and it encompasses immunologic responses,
susceptibility genes, environmental triggers, and compro-
mised skin-barrier function [1]. The skin lesions of AD
patients are characterized by the presence of inﬂammatory
inﬁltrates consisting of T lymphocytes, monocytes/macro-
phages, eosinophils, and mast cells [5]. Steroidal drugs like
corticosteroids are commonly prescribed for the alleviation
of the symptoms of AD. However, the repeated use of
corticosteroidscancausesevereskinatrophy,susceptibilityto6 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Blood IgE level. Blood was taken from each mouse at
the end of the experiment, and the blood IgE level was measured
using mouse IgE-speciﬁc ELISA kit. aP<0.05 and bP<0.01 versus
control.
Control NL5 NL25 NL50
N
u
m
b
e
r
s
0
10
20
30
40
50
60
70
b
a
Figure 6: Eﬀect of NL on scratching behavior. The scratching
behavior of each mouse was videotaped for 10 minutes on day
25 after sensitization. Scratching of the nose, ears, and dorsal skin
with the hind paws was observed during play back. aP<0.05 and
bP<0.01 versus control.
infection, and adrenal suppression [16]. NC/Nga mice, orig-
inated from Japanese fancy mice as an inbred line, whenever
raised in conventional circumstances spontaneously develop
AD-like skin lesions characterized by increased number
of eosinophils, mast cells, lymphocytes, and macrophages
[4]. Although SPF NC/Nga mice showed neither clinical
signs nor IgE hyperproduction, application of haptens or
mite antigens is necessary to evoke the eczema stably [17].
Consistent with these reports, epicutaneous sensitization
and challenge of dorsal skin of NC/Nga mice with DNCB
evoked the incidence of AD like skin lesions. Histological
examination of skin lesion stained by hematoxylin and eosin
and toluidine blue revealed the thickening of epidermis and
dermis because of leukocyte inﬁltration, hyperplasia, dermis
ulcer, and inﬁltration of immunocytes on the skin such as T
cell, mast cell, and eosinophils. In NL-administered groups,
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Figure 7: Eﬀect of NL on TEWL. TEWL was measured every
week for 4 weeks after sensitization using Tewameter (TM300).
Measurements were recorded when TEWL readings were stabilized
at approximately 30 seconds after the probe was placed on the skin.
bP<0.01versus control.
the thickness of epidermis and dermis was reduced and the
inﬁltration of immunocytes was signiﬁcantly decreased as
compared to control. Excessive production of chemokine
such as thymus and activated-regulation chemokine (TARC)
by activated keratinocytes attracts the immunocyte into
the epidermis resulting in acanthosis [4]. In our in vitro
study, treatment of NL (250 and 500µg/mL) for 24 hours
signiﬁcantly inhibited the production of TARC by activated
keratinocyte (data not shown) suggesting that inhibition
of TARC inhibited the inﬁltration of immunocytes thereby
inhibiting epidermal thickening. Moreover, Th2-speciﬁc
chemokines, TARC, and monocyte-derived chemotactic
cytokine, and their receptor, CCR4, have been reported to
be highly expressed in the lesions of the NC/Nga mice
[4]. Haptens such as picryl chloride are commonly used
to induce allergic dermatitis and have been thought to
evoke primarily a Th1-dominated response. However, it has
been recently reported that multiple challenges with picryl
chloride to the skin of mice over an extended period cause
the skin inﬂammation to shift to a chronic Th2-dominated
inﬂammatory response that is similar to human AD [18].
It is well established that the elevation of serum IgE in
AD may be due to the Th1/Th2 imbalance skewed to Th2,
which plays important roles in the pathology of AD [19].
Mast cells, a critical participant in the various biologi-
cal processes including allergic diseases and inﬂammatory
reaction, store biologically potent inﬂammatory mediator
such as histamine and express on their surface membrane
receptors with high aﬃnity and speciﬁcity for IgE [20]. The
interaction of antigen with surface-bound IgE initiates a
series of biochemical events that culminates in the release of
histamine and the production of cytokines [21]. Histological
examinations revealed that NL possessed the signiﬁcant
inhibitory eﬀect on mast cell degranulation possibly due to
inhibition of IgE hyperproduction. Pruritus, an unpleasantEvidence-Based Complementary and Alternative Medicine 7
sensation provoking the desire to scratch in AD, might be
due to histamine, proteases, and cytokines from various cells
including degranulated mast cells [22]. In our study, NL
inhibited the episode of scratching which might be due to
inhibition of degranulation of mast cells. Xeroderma and
skin barrier dysfunction, which are associated with AD, are
due to lower level of ceramides that accelerate TEWL and
decrease water capacitance resulting in atopic dry skin [23].
In our study, administration of NL inhibited TEWL thereby
improving the skin condition. Although the hapten-repeated
sensitization model is not a genetically driven model, many
of its aspects may be applicable to extrinsic allergen-driven
AD. In conclusion, we demonstrated that the oral admin-
istration of NL inhibited the development of AD like skin
lesions in NC/Nga mice induced by repeated epicutaneous
sensitization of the dorsal skin by DNCB. NL contains
abundant amount of ﬂavonoids like luteolin, quercetrin, and
isoquercitrin [15] as pharmacologically active components.
Theanti-inﬂammatoryeﬀectofthoseﬂavonoidssuggeststhe
possibility of their therapeutic eﬃcacy in various inﬂamma-
tory diseases [24]. Furthermore, oral administration of NL
for 4 weeks had no remarkable toxic eﬀects such as reduction
of food intake and body weight. Thus, the results from
our experiment suggest that NL can be a potential natural
resourceforthemanagementofADalthoughthemechanism
of action involved in the treatment remains to be explored.
5. Conclusions
The present study provides evidencethat oral administration
of N. nucifera leaf extract attenuated the DNCB-induced
atopic dermatitis like skin lesions in NC/Nga mice. Although
we studied the eﬀect of NL in chemical antigen-induced
model, many of its aspects may be applicable to extrinsic
allergen-driven AD.
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